PDCD1 and neoplasm: Furthermore, a higher number of MDSCs, higher PD-1+/CD8+ TIL ratio, lower stromal PD-L1 immune cell score, and elevated PD-L1 H-score of tumor cells were significantly associated with worse prognosis.